Open AccessJournal Article
Adverse effects associated with sublingual immunotherapy.
Reads0
Chats0
About:
This article is published in Clinical allergy and immunology.The article was published on 2008-01-01 and is currently open access. It has received 3 citations till now.read more
Citations
More filters
Journal ArticleDOI
Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI
Fernando Monteiro Aarestrup,Ernesto Akio Taketomi,Clóvis Eduardo Santos Galvão,Elaine Gagete,Anna Caroline Nóbrega Machado Arruda,Gil Bardini Alves,Geórgia Véras de Araújo Gueiros Lira,Marcos Reis Gonçalves,Mariana Graça Couto Miziara,Sidney Souteban Maranhão Casado,Simone Valadão Curi,Veridiana Aun Rufino Pereira,Valéria Soraya de Farias Sales,Dirceu Solé,Norma de Paula Motta Rubini,Emanuel Sávio Cavalcanti Sarinho +15 more
TL;DR: The most prevalent house dust mites are Dermatophagoides pteronyssinus, Dermataphagoides farinae and their allergens have the highest clinical relevance as mentioned in this paper .
Uso de vacuna Valergen DP en la rinitis alérgica
Adianez Sugrañes Montalván,Marelys Hernández Veiga,María Morales Menéndez,Eduardo Barreto Suárez,Arianna Sugrañes Montalván,Andrés Ramírez Torres +5 more
TL;DR: La inmunoterapia sublingual con Dermatophagoide pteronyssinus es eficaz and segura para el tratamiento de los pacientes con rinitis alergica.
References
More filters
Journal ArticleDOI
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Jean Bousquet,N. Khaltaev,Alvaro A. Cruz,Judah A. Denburg,W. J. Fokkens,Alkis Togias,T. Zuberbier,Carlos E. Baena-Cagnani,Giorgio Walter Canonica,C. van Weel,Ioana Agache,Nadia Aït-Khaled,Claus Bachert,Michael S. Blaiss,Sergio Bonini,L.-P. Boulet,Philippe-Jean Bousquet,Paulo Augusto Moreira Camargos,K-H. Carlsen,Y. Z. Chen,Adnan Custovic,Ronald Dahl,Pascal Demoly,H. Douagui,Stephen R. Durham,R. Gerth van Wijk,O. Kalayci,Michael A. Kaliner,You Young Kim,Marek L. Kowalski,Piotr Kuna,L. T. T. Le,Catherine Lemière,Jing Li,Richard F. Lockey,S. Mavale-Manuel,Eli O. Meltzer,Y. Mohammad,J Mullol,Robert M. Naclerio,Robyn E O'Hehir,K. Ohta,S. Ouedraogo,S. Palkonen,Nikolaos G. Papadopoulos,Gianni Passalacqua,Ruby Pawankar,Todor A. Popov,Klaus F. Rabe,J Rosado-Pinto,G. K. Scadding,F. E. R. Simons,Elina Toskala,E. Valovirta,P. Van Cauwenberge,De Yun Wang,Magnus Wickman,Barbara P. Yawn,Arzu Yorgancioglu,Osman M. Yusuf,H. J. Zar,Isabella Annesi-Maesano,E.D. Bateman,A. Ben Kheder,Daniel A. Boakye,J. Bouchard,Peter Burney,William W. Busse,Moira Chan-Yeung,Niels H. Chavannes,A.G. Chuchalin,William K. Dolen,R. Emuzyte,Lawrence Grouse,Marc Humbert,C. M. Jackson,Sebastian L. Johnston,Paul K. Keith,James P. Kemp,J. M. Klossek,Désirée Larenas-Linnemann,Brian J. Lipworth,Jean-Luc Malo,Gailen D. Marshall,Charles K. Naspitz,K. Nekam,Bodo Niggemann,Ewa Nizankowska-Mogilnicka,Yoshitaka Okamoto,M. P. Orru,Paul Potter,David Price,Stuart W. Stoloff,Olivier Vandenplas,Giovanni Viegi,Dennis M. Williams +95 more
TL;DR: The ARIA guidelines for the management of allergic rhinitis and asthma are similar in both the 1999 ARIA workshop report and the 2008 Update as discussed by the authors, but the GRADE approach is not yet available.
Journal ArticleDOI
Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis
TL;DR: This study confirms dose-dependent efficacy of the grass allergen tablet and indicates that the greater tolerability of the tablet may permit immunotherapy to be available to a much broader group of patients with impaired quality of life caused by grass pollen allergy.
Journal ArticleDOI
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
Ronald Dahl,Alexander Kapp,Giselda Colombo,Jan G.R. de Monchy,Sabina Rak,W. Emminger,Montserrat Fernandez Rivas,Mette Ribel,Stephen R. Durham +8 more
TL;DR: Sublingual immunotherapy with grass allergen tablets was effective in grass pollen-induced rhinoconjunctivitis and represents a safe alternative to injection immunotherapy suitable for home use.
Journal ArticleDOI
Sublingual immunotherapy: a comprehensive review.
Linda Cox,Désirée Larenas Linnemann,Hendrik Nolte,David Weldon,Ira Finegold,Harold S. Nelson +5 more
TL;DR: Despite clear evidence that SLIT is an effective treatment, many questions remained unanswered, including effective dose, treatment schedules, and overall duration of treatment, and an assessment of the cost/benefit ratio of the treatment cannot be made.
Journal ArticleDOI
Allergic rhinitis and its impact on asthma update: allergen immunotherapy.
TL;DR: The clinical efficacy of injection immunotherapy in rhinitis and asthma was confirmed, as well as the safety, provided that recommendations are followed, and current data indicate that sublingual immunotherapy is safe and the rate of adverse reactions is not greater below 5 years of age.